Turkish league against rheumatism (TLAR) recommendations for the pharmacological management of rheumatoid arthritis: 2018 update under guidance of current recommendations

Simple item page
dc.contributor.authorAtaman Ş.
dc.contributor.authorSunar İ.
dc.contributor.authorYilmaz G.
dc.contributor.authorBodur H.
dc.contributor.authorNas K.
dc.contributor.authorAyhan F.F.
dc.contributor.authorAkgül Ö.
dc.contributor.authorAkinci A.
dc.contributor.authorAltay Z.
dc.contributor.authorBirtane M.
dc.contributor.authorSOY Buğdayci D.
dc.contributor.authorÇapkin E.
dc.contributor.authorÇevik R.
dc.contributor.authorGarİp Çimen Y.
dc.contributor.authorDuruöz M.T.
dc.contributor.authorElhan A.H.
dc.contributor.authorGürer G.
dc.contributor.authorKaçar C.
dc.contributor.authorKamanli A.
dc.contributor.authorKaptanoğlu E.
dc.contributor.authorKaya T.
dc.contributor.authorKocabaş H.
dc.contributor.authorKuru Ö.
dc.contributor.authorAlkan Melikoğlu M.
dc.contributor.authorÖzel S.
dc.contributor.authorRezvani A.
dc.contributor.authorSezer İ.
dc.contributor.authorYurdakul F.G.
dc.date.accessioned2024-07-22T08:09:27Z
dc.date.available2024-07-22T08:09:27Z
dc.date.issued2018
dc.description.abstractObjectives: This study aims to report the assessment of the Turkish League Against Rheumatism (TLAR) expert panel on the compliance and adaptation of the European League Against Rheumatism (EULAR) 2016 recommendations for the management of rheumatoid arthritis (RA) in Turkey. Patients and methods: The EULAR 2016 recommendations for the treatment of RA were voted by 27 specialists experienced in this field with regard to participation rate for each recommendation and significance of items. Afterwards, each recommendation was brought forward for discussion and any alteration gaining ≥70% approval was accepted. Also, Turkish version of each item was rearranged. Last version of the recommendations was then revoted to determine the level of agreement. Levels of agreement of the two voting rounds were compared with Wilcoxon signed-rank test. In case of significant difference, the item with higher level of agreement was accepted. In case of no difference, the changed item was selected. Results: Four overarching principles and 12 recommendations were assessed among which three overarching principles and one recommendation were changed. The changed overarching principles emphasized the importance of physical medicine and rehabilitation specialists as well as rheumatologists for the care of RA patients in Turkey. An alteration was made in the eighth recommendation on treatment of active RA patients with unfavorable prognostic indicators after failure of three conventional disease modifying anti-rheumatic drugs. Remaining principles were accepted as the same although some alterations were suggested but could not find adequate support to reach significance. Conclusion: Expert opinion of the TLAR for the treatment of RA was composed for practices in Turkish rheumatology and/or physical medicine and rehabilitation clinics. © 2018 Turkish League Against Rheumatism. All rights reserved.
dc.identifier.DOI-ID10.5606/ArchRheumatol.2018.6911
dc.identifier.issn21485046
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14829
dc.language.isoEnglish
dc.publisherTurkish League Against Rheumatism (TLAR)
dc.rightsAll Open Access; Gold Open Access
dc.subjectadalimumab
dc.subjectC reactive protein
dc.subjectcertolizumab pegol
dc.subjectetanercept
dc.subjecthydroxychloroquine
dc.subjectimmunoglobulin M
dc.subjectleflunomide
dc.subjectmethotrexate
dc.subjectsalazosulfapyridine
dc.subjecttocilizumab
dc.subjectArticle
dc.subjectDAS28
dc.subjectdecision making
dc.subjectdisease activity
dc.subjectechography
dc.subjecterythrocyte sedimentation rate
dc.subjectEuropean League Against Rheumatism
dc.subjecthuman
dc.subjectmedical society
dc.subjectmonotherapy
dc.subjectrehabilitation medicine
dc.subjectrheumatoid arthritis
dc.subjectrheumatologist
dc.subjectsensitivity and specificity
dc.subjectTurkish League Against Rheumatism
dc.titleTurkish league against rheumatism (TLAR) recommendations for the pharmacological management of rheumatoid arthritis: 2018 update under guidance of current recommendations
dc.typeArticle

Files

Collections

Scopus Koleksiyonu